Trials / Conditions / Metastatic Neuroendocrine Carcinoma
Metastatic Neuroendocrine Carcinoma
3 registered clinical trials studyying Metastatic Neuroendocrine Carcinoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Testing the Addition of an Anti-cancer Drug, BAY 1895344, to Usual Chemotherapy for Advanced Stage Solid Tumor NCT04514497 | National Cancer Institute (NCI) | Phase 1 |
| Active Not Recruiting | Testing the Combination of XL184 (Cabozantinib), Nivolumab, and Ipilimumab for Poorly Differentiated Neuroendo NCT04079712 | National Cancer Institute (NCI) | Phase 2 |
| Active Not Recruiting | Nivolumab and Temozolomide in Treating Patients With Recurrent or Refractory Small-Cell Lung Cancer or Advance NCT03728361 | Dwight Owen | Phase 2 |